Summary
90.06 0.70(0.78%)10/14/2024
Medtronic Plc (MDT)
Medtronic Plc (MDT)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.77 | 3.46 | -0.04 | 16.90 | 12.27 | 25.52 | -7.03 | 46,677.13 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 90.06 | |
| Open | 89.53 | |
| High | 90.06 | |
| Low | 89.15 | |
| Volume | 2,658,158 | |
| Change | 0.69 | |
| Change % | 0.77 | |
| Avg Volume (20 Days) | 3,029,065 | |
| Volume/Avg Volume (20 Days) Ratio | 0.88 | |
| 52 Week Range | 68.84 - 91.49 | |
| Price vs 52 Week High | -1.56% | |
| Price vs 52 Week Low | 30.83% | |
| Range | 0.59 | |
| Gap Up/Down | -0.06 | |
Fundamentals | ||
| Market Capitalization (Mln) | 114,719 | |
| EBIDTA | 8,677,000,192 | |
| PE Ratio | 26.2984 | |
| PEG Ratio | 1.5178 | |
| WallStreet Target Price | 94.00 | |
| Book Value | 38.9520 | |
| Earnings Per Share | 3.1500 | |
| EPS Estimate Current Quarter | 1.2600 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 5.2000 | |
| EPS Estimate Next Year | 5.4500 | |
| Diluted EPS (TTM) | 3.1500 | |
| Revenues | ||
| Profit Marging | 0.1300 | |
| Operating Marging (TTM) | 0.1917 | |
| Return on asset (TTM) | 0.0423 | |
| Return on equity (TTM) | 0.0817 | |
| Revenue TTM | 32,320,000,000 | |
| Revenue per share TTM | 24.2980 | |
| Quarterly Revenue Growth (YOY) | 0.0470 | |
| Quarterly Earnings Growth (YOY) | 0.0780 | |
| Gross Profit (TTM) | 21,715,000,000 | |
| Dividends | ||
| Dividend Share | 2.7500 | |
| Dividend Yield | 0.0333 | |
| Valuations | ||
| Trailing PE | 26.2984 | |
| Forward PE | 14.6628 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.0543 | |
| Revenue Enterprise Value | 3.8137 | |
| EBITDA Enterprise Value | 13.8354 | |
| Shares | ||
| Shares Outstanding | 1,327,820,032 | |
| Shares Float | 1,325,498,850 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.01 | |
| Insider (%) | 0.11 | |
| Institutions (%) | 85.31 | |
10/11 18:57 EST - zacks.com
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the latest trading session, Medtronic (MDT) closed at $89.36, marking a +0.57% move from the previous day.
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the latest trading session, Medtronic (MDT) closed at $89.36, marking a +0.57% move from the previous day.
10/10 08:05 EST - seekingalpha.com
Medtronic: Undervalued Dividend Aristocrat With High Margins
Medtronic remains an attractive investment due to its diversified revenue streams, robust product pipeline and improving margins. MDT's growth is driven by strong performance in Neuroscience, Cardiovascular, and Diabetes care, with significant international revenue growth and a promising product pipeline. Trading below its historical valuation, MDT offers a compelling opportunity for conservative investors seeking quality at a reasonably low price.
Medtronic: Undervalued Dividend Aristocrat With High Margins
Medtronic remains an attractive investment due to its diversified revenue streams, robust product pipeline and improving margins. MDT's growth is driven by strong performance in Neuroscience, Cardiovascular, and Diabetes care, with significant international revenue growth and a promising product pipeline. Trading below its historical valuation, MDT offers a compelling opportunity for conservative investors seeking quality at a reasonably low price.
10/09 13:32 EST - zacks.com
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?
The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?
The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.
10/09 12:17 EST - seekingalpha.com
Buy 4 October Dividend Aristocrats & Watch 10
"Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 2024 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 10.5%-20.13% topped-by Franklin & Target.
Buy 4 October Dividend Aristocrats & Watch 10
"Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 2024 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 10.5%-20.13% topped-by Franklin & Target.
10/09 04:15 EST - zacks.com
The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International
JPMorgan, Medtronic, Shopify and Perma-Pipe International are included in this Analyst Blog.
The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International
JPMorgan, Medtronic, Shopify and Perma-Pipe International are included in this Analyst Blog.
10/04 18:56 EST - zacks.com
Medtronic (MDT) Advances But Underperforms Market: Key Facts
Medtronic (MDT) concluded the recent trading session at $88.26, signifying a +0.56% move from its prior day's close.
Medtronic (MDT) Advances But Underperforms Market: Key Facts
Medtronic (MDT) concluded the recent trading session at $88.26, signifying a +0.56% move from its prior day's close.
10/04 07:28 EST - marketwatch.com
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Company says the smallest knock can impact batteries by damaging internal electronics
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Company says the smallest knock can impact batteries by damaging internal electronics
10/04 06:45 EST - prnewswire.com
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland , Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump. Medtronic began investigating this issue upon receiving customer reports of shortened battery life and a comprehensive analysis found that pumps that have been dropped, bumped, or experienced physical impact even once may result in shortened battery life due to damage to internal electrical components.
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland , Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump. Medtronic began investigating this issue upon receiving customer reports of shortened battery life and a comprehensive analysis found that pumps that have been dropped, bumped, or experienced physical impact even once may result in shortened battery life due to damage to internal electrical components.
10/02 12:15 EST - globenewswire.com
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Mexico Spinal Implants Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Cervical Fixation Market, Thoracolumbar Fixation Market, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, Mexico's spinal implant and VCF market reached a valuation exceeding $135 million. Projected to grow at a CAGR of 6.1%, the market is expected to surpass $205 million by 2030. This comprehensive report on the Mexican spinal implant and VCF market covers various segments, including traditional cervical and thoracolumbar fixation devices, interbody devices, motion preservation devices, VCF treatment, electrical stimulation devices, and spinal surgery instrumentation. Key Market Data Insights:
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Mexico Spinal Implants Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Cervical Fixation Market, Thoracolumbar Fixation Market, and 4 more" report has been added to ResearchAndMarkets.com's offering. In 2023, Mexico's spinal implant and VCF market reached a valuation exceeding $135 million. Projected to grow at a CAGR of 6.1%, the market is expected to surpass $205 million by 2030. This comprehensive report on the Mexican spinal implant and VCF market covers various segments, including traditional cervical and thoracolumbar fixation devices, interbody devices, motion preservation devices, VCF treatment, electrical stimulation devices, and spinal surgery instrumentation. Key Market Data Insights:
10/01 11:20 EST - zacks.com
Reasons to Retain Medtronic Stock in Your Portfolio Now
Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.
Reasons to Retain Medtronic Stock in Your Portfolio Now
Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.
10/01 10:00 EST - globenewswire.com
GI Alliance Collaborates with Medtronic to Introduce GI Genius™ AI Technology for Enhanced Colon Polyp Detection
Intelligent endoscopy module to be delivered to more than 400 GI Alliance site locations Intelligent endoscopy module to be delivered to more than 400 GI Alliance site locations
GI Alliance Collaborates with Medtronic to Introduce GI Genius™ AI Technology for Enhanced Colon Polyp Detection
Intelligent endoscopy module to be delivered to more than 400 GI Alliance site locations Intelligent endoscopy module to be delivered to more than 400 GI Alliance site locations
09/30 09:15 EST - zacks.com
Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock
Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.
Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock
Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.
09/27 19:00 EST - prnewswire.com
New clinical data demonstrate excellent lesion durability with PulseSelect™ Pulsed Field Ablation System in real-world setting as approvals and adoption expand globally
APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopy Successful launch in Japan follows recent reimbursement approval Approvals across APAC including China and Australia broaden reach for patients GALWAY, Ireland and SYDNEY, Sept. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the presentation of clinical study results demonstrating a high rate of durable lesion formation for the PulseSelect™ Pulsed Field Ablation (PFA) System in treating atrial fibrillation (Afib).
New clinical data demonstrate excellent lesion durability with PulseSelect™ Pulsed Field Ablation System in real-world setting as approvals and adoption expand globally
APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopy Successful launch in Japan follows recent reimbursement approval Approvals across APAC including China and Australia broaden reach for patients GALWAY, Ireland and SYDNEY, Sept. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the presentation of clinical study results demonstrating a high rate of durable lesion formation for the PulseSelect™ Pulsed Field Ablation (PFA) System in treating atrial fibrillation (Afib).
09/27 10:47 EST - zacks.com
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
09/27 09:19 EST - seekingalpha.com
My Best Dividend Aristocrats For October 2024
The ProShares S&P 500 Dividend Aristocrats ETF extends it's good form in the second half of 2024, adding a gain of 3.69% in August. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 38 months of tracking these strategies, all 3 strategies are generating a CAGR superior to NOBL while also offering a higher starting dividend yield.
My Best Dividend Aristocrats For October 2024
The ProShares S&P 500 Dividend Aristocrats ETF extends it's good form in the second half of 2024, adding a gain of 3.69% in August. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 38 months of tracking these strategies, all 3 strategies are generating a CAGR superior to NOBL while also offering a higher starting dividend yield.
09/26 16:17 EST - prnewswire.com
Federated Hermes, Inc. launches MDT Mid Cap Growth Collective Investment Fund
Newest MDT product aims to meet growing demand for retirement products PITTSBURGH , Sept. 26, 2024 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investment management, today announced the launch of the Federated Hermes MDT Mid Cap Growth Collective Investment Fund, a strategy for qualified retirement plan investors.
Federated Hermes, Inc. launches MDT Mid Cap Growth Collective Investment Fund
Newest MDT product aims to meet growing demand for retirement products PITTSBURGH , Sept. 26, 2024 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investment management, today announced the launch of the Federated Hermes MDT Mid Cap Growth Collective Investment Fund, a strategy for qualified retirement plan investors.
09/26 11:23 EST - fool.com
The Smartest Dividend Stocks to Buy With $10,000 Right Now
Black Hills is a boring Dividend King utility with an above average yield. Realty Income is a giant landlord with a reliable monthly dividend and an above average yield.
The Smartest Dividend Stocks to Buy With $10,000 Right Now
Black Hills is a boring Dividend King utility with an above average yield. Realty Income is a giant landlord with a reliable monthly dividend and an above average yield.
09/26 11:05 EST - zacks.com
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.
09/25 08:00 EST - prnewswire.com
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
GALWAY, Ireland and CHICAGO , Sept. 25, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations.
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
GALWAY, Ireland and CHICAGO , Sept. 25, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations.
09/19 15:07 EST - seekingalpha.com
Going Ex-Dividend
Just over a tenth of the stocks in the S&P 500 are going ex-dividend in the next two weeks. If the ex-dividend date is 9/20/24, for example, you'd need to own shares as of the close on 9/19/24 to capture the dividend. Some of the highest-yielding stocks going ex-dividend in the next two weeks include Eversource Energy, Philip Morris International, Franklin Resources, US Bancorp, and Host Hotels.
Going Ex-Dividend
Just over a tenth of the stocks in the S&P 500 are going ex-dividend in the next two weeks. If the ex-dividend date is 9/20/24, for example, you'd need to own shares as of the close on 9/19/24 to capture the dividend. Some of the highest-yielding stocks going ex-dividend in the next two weeks include Eversource Energy, Philip Morris International, Franklin Resources, US Bancorp, and Host Hotels.